Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01327729|
Recruitment Status : Unknown
Verified March 2011 by BioGeneric Pharma.
Recruitment status was: Recruiting
First Posted : April 4, 2011
Last Update Posted : April 4, 2011
Xiamen Amoytop Biotech Co., Ltd.
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||April 2011|
|Estimated Study Completion Date :||May 2013|